Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Harpoon Therapeutics, Inc. HARP
$0.79
-$0.03 (-4.28%)
На 18:01, 12 мая 2023
+786.08%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
31136842.00000000
-
week52high
3.36
-
week52low
0.54
-
Revenue
31915000
-
P/E TTM
0
-
Beta
1.55466900
-
EPS
-1.92000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic cancer, and other mesothelin-expressing tumors. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Truist Securities | Buy | Buy | 23 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 15 авг 2022 г. |
| SVB Leerink | Outperform | Outperform | 11 авг 2022 г. |
| Piper Sandler | Overweight | Overweight | 11 авг 2022 г. |
| Wedbush | Outperform | Neutral | 16 мая 2022 г. |
| Citigroup | Buy | Buy | 29 авг 2022 г. |
| SVB Leerink | Outperform | Outperform | 15 ноя 2022 г. |
| Baird | Neutral | Outperform | 15 ноя 2022 г. |
| Truist Securities | Hold | Buy | 14 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| EASTLAND JULIA MARIE | A | 407600 | 407600 | 24 янв 2023 г. |
| Walker Luke Nathaniel | A | 100000 | 100000 | 24 янв 2023 г. |
| Lanza Frank J | A | 65000 | 65000 | 24 янв 2023 г. |
| Lanza Frank J | A | 86438 | 86438 | 22 ноя 2022 г. |
| Walker Luke Nathaniel | A | 305000 | 305000 | 03 окт 2022 г. |
| SILVERNAIL LAUREN P | A | 20335 | 20335 | 15 сент 2022 г. |
| Viney Joanne L. | A | 37500 | 37500 | 22 июн 2022 г. |
| Viney Joanne L. | A | 10167 | 10167 | 22 июн 2022 г. |
| Robbins Andrew R | A | 10167 | 10167 | 22 июн 2022 г. |
| HUNT RONALD | A | 32142 | 32142 | 22 июн 2022 г. |
Новостная лента
The 3 Most Undervalued Penny Stocks to Buy in February 2023
InvestorPlace
02 февр 2023 г. в 11:28
If finding undervalued stocks is good, then finding undervalued penny stocks is even better. That's because, with penny stocks, investors' capital appreciation upside potential is amplified.
New Strong Buy Stocks for January 27th
Zacks Investment Research
27 янв 2023 г. в 08:17
GWRS, EVBG, SPLK, RELL and HARP have been added to the Zacks Rank #1 (Strong Buy) List on January 27, 2023.
Why Fast-paced Mover Harpoon Therapeutics, Inc. (HARP) Is a Great Choice for Value Investors
Zacks Investment Research
25 янв 2023 г. в 10:33
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Harpoon Therapeutics, Inc. (HARP) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
7 Stocks to Add to Your 10x Watchlist
InvestorPlace
16 дек 2022 г. в 12:09
There are few things that get growth investors excited like the opportunity to invest in 10x stocks. By definition, these 10x stocks (also referred to as 10 baggers) can add huge gains to your portfolio.
Harpoon Therapeutics Remains Volatile After Promising News
MarketBeat
14 дек 2022 г. в 01:01
Harpoon Therapeutics offers an example of biotech's volatility. The stock advanced as much as 191% intraday Monday before settling down to a gain of 22.61%.